Results 111 to 120 of about 70,175 (258)

Trends in Medicare Part B Spending on Discarded Drugs, 2017-2020.

JAMA Intern Med, 2023
O'Donoghue AL, White MH, Weiss AP, Stevens JP, Anderson TS.   +4 more
europepmc   +1 more source

Capturing Financial Burden Concerns in an ALS Multidisciplinary Clinic

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Amyotrophic lateral sclerosis (ALS) is associated with substantial financial burden. How financial concerns are documented or addressed in ALS multidisciplinary clinics (MDC) is unclear. We aimed to characterize financial concerns among people living with ALS (pALS) and how they are identified and documented by ...
Nikhita Pathapati, Minh Nguyen, Jaden Ju, Mahita Maddukuri, John Kiehl, Elizabeth Kvale, Aaron P. Thrift, Sarah Berth, Astrid Grouls   +8 more
wiley   +1 more source

Sacral Neuromodulation in the Management of Refractory Pediatric Lower Urinary Tract Dysfunction

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Sacral neuromodulation is currently used in the pediatric patient population for refractory lower urinary tract dysfunction (LUTD). Evidence, however, is currently limited for institutional experiences of long‐term outcomes for sacral neuromodulation in the pediatric patient population.
Megan A. Stout, Lauren E. Corona, Li‐Ching Huang, Tatsuki Koyama, Lindsay A. Gil, Shelly King, Benjamin M. Whittam, Seth A. Alpert, John C. Pope   +8 more
wiley   +1 more source

Survey to assess the economic stability and mental health of households with people receiving enteral and parenteral nutrition

Nutrition in Clinical Practice, EarlyView.
Abstract Background The landscape of nutrition support faces challenges, including rising costs, product shortages, reimbursement gaps, and infusion providers closing. This nationwide survey aimed to describe the perceptions and attitudes related to costs, therapy access, and mental health among households with at least one family member requiring ...
Gabriela Gardner, Ryan Butcher, Brooks D. Cash   +2 more
wiley   +1 more source

Identifying DASH Adherence Patterns and Their Association With Dietary Behaviors Among Adults With Hypertension

Research in Nursing &Health, EarlyView.
ABSTRACT The Dietary Approaches to Stop Hypertension (DASH) diet is effective in lowering blood pressure yet adherence to DASH remains low. Intuitive eating, a behavior that emphasizes responsiveness to hunger and satiety cues, may influence DASH adherence but has not been well studied among adults with hypertension.
Youran Lee, Melissa C. Kay, Anushka Palipana, Sandy Askew, Miriam B. Berger, Hailey N. Miller, Gary G. Bennett, Qing Yang   +7 more
wiley   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

Obesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu, Hao Dai, Huilin Tang, William T. Donahoo, Thomas J. George, Ramon C. Sun, Sizun Jiang, Aik Choon Tan, Yi Guo, Jonathan D. Licht, John M. Allen, Kelvin P. Lee, Jingchuan Guo, Jiang Bian   +13 more
wiley   +1 more source

Responses to GLP‐1RA in White and Black Adults With Obesity: Insights From Generalized Additive Mixed Models of EHR Data

Obesity, EarlyView.
ABSTRACT Objective This study examined racial differences in weight loss and clinical response to glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) therapy among adults with obesity using real‐world data. Methods We retrospectively analyzed our institution's Research Data Warehouse (RDW) containing deidentified data from electronic health records ...
Jordan H. Mallette, Joshua S. Speed, Seth T. Lirette, Daniel Moore, John S. Clemmer   +4 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonist‐Based Agents and Body Composition: Filling More Gaps

Obesity, EarlyView.
ABSTRACT The last 2 decades have seen historic advances in the treatment of obesity. We are entering an era of defining obesity not by weight‐based outcomes but by changes in body composition. Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are forming the platform for obesity treatments based on their high level of efficacy. Body composition can
Robert L. Dubin, Tierra N. Sanders, Hunter M. Schwab, Steven B. Heymsfield, Frank L. Greenway   +4 more
wiley   +1 more source

Trends in Diagnosing Obesity: The CALOR Study

Obesity, EarlyView.
Data from the CALOR study suggest that in people with elevated BMI in the US and Japan, there is underdiagnosis of obesity and a high prevalence of diseases interrelated to obesity. ABSTRACT Objective This study aimed to describe characteristics of people with elevated BMI by presence versus absence of obesity diagnosis and trends over time.
Deborah B. Horn, Eva Lesén, Christen M. Gray, Magnus Bjursell, Hironori Waki   +4 more
wiley   +1 more source

Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market.

JAMA Health Forum, 2021
Dean EB, Bond AM.
europepmc   +1 more source